Glycometabolic State at Admission: Important Risk Marker of Mortality in Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Infarction
Klas Malmberg(Nordic School of Public Health), Lars Rydén(Karolinska Institutet), Hans Wedel(Sahlgrenska University Hospital), Anna Norhammar
Cited by 853
Related Papers
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial
|The Lancet|1998|5.8k
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
|The Lancet|2002|5.4k
Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects
|New England Journal of Medicine|2007|4.6k
Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years after Bariatric Surgery
|New England Journal of Medicine|2004|4.5k